Live from the NIH registry
Studies recruiting near Kalamazoo right now
Top 25 of 104 recruiting studies, sorted by proximity — each links to its official registry page
Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs
First Episode Psychosis
Phase 4
Interventional 300 participants sought
InterAct of Michigan — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Northwell Health
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Rectal Cancer
Phase 3
Interventional 250 participants sought
West Michigan Cancer Center — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Canadian Cancer Trials Group
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
Paragon Health, Inc — Kalamazoo, Michigan (1.2 mi)
· Sponsor: CSL Behring
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
West Michigan Cancer Center — Kalamazoo, Michigan (1.2 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
WMU Homer Stryker MD School of Medicine — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Novo Nordisk A/S
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
Acute Ischemic Stroke
Phase 3
Interventional 404 participants sought
Bronson Methodist Hospital/Western Michigan University Homer Stryker M.D. School of Medicine — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Mercy Health Ohio
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8
Phase 3
Interventional 304 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Children's Oncology Group
Quality of End-of-Life Care for Children With Cancer
Childhood Hematopoietic and Lymphatic System Neoplasm, Childhood Malignant Solid Neoplasm
N/A
Observational 2,425 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Children's Oncology Group
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Cutaneous Melanoma, Stage II
N/A
Interventional 2,998 participants sought
West Michigan Cancer Centre — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Melanoma and Skin Cancer Trials Limited
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: NRG Oncology
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
West Michigan Cancer Center — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: SWOG Cancer Research Network
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Schizophrenia
Phase 1
Interventional 64 participants sought
Western Michigan University — Kalamazoo, Michigan (1.2 mi)
· Sponsor: Janssen Research & Development, LLC
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia
Phase 2
Interventional 153 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Phase 3
Interventional 336 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma
Phase 2
Interventional 396 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: SWOG Cancer Research Network
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 306 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma
Phase 2
Interventional 46 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi)
· Sponsor: National Cancer Institute (NCI)